Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens

Nature Biotechnology
Volume 38 Issue 3, March 2020
https://www.nature.com/nbt/volumes/38/issues/3

 

Article | 13 January 2020
Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens
Cancer vaccines that self-assemble into uniform nanoparticles improve tumor clearance.
Geoffrey M. Lynn, Christine Sedlik[…] & Robert A. Seder